Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

β-Arrestin-2 Counters CXCR7-Mediated EGFR Transactivation and Proliferation.

Kallifatidis G, Munoz D, Singh RK, Salazar N, Hoy JJ, Lokeshwar BL.

Mol Cancer Res. 2016 May;14(5):493-503. doi: 10.1158/1541-7786.MCR-15-0498. Epub 2016 Feb 26.

2.

β-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Protein.

Yin D, Yang X, Li H, Fan H, Zhang X, Feng Y, Stuart C, Hu D, Caudle Y, Xie N, Liu Z, LeSage G.

J Biol Chem. 2016 Jan 8;291(2):605-12. doi: 10.1074/jbc.M115.655829. Epub 2015 Nov 18.

3.

The human embryonic stem cell proteome revealed by multidimensional fractionation followed by tandem mass spectrometry.

Zhao P, Schulz TC, Sherrer ES, Weatherly DB, Robins AJ, Wells L.

Proteomics. 2015 Jan;15(2-3):554-66. doi: 10.1002/pmic.201400132. Epub 2014 Dec 17.

4.

β-arrestin 2-mediated immune suppression induced by chronic stress.

Li H, Smalligan DA, Xie N, Javer A, Zhang Y, Hanley G, Yin D.

Neuroimmunomodulation. 2011;18(3):142-9. doi: 10.1159/000322868. Epub 2011 Jan 11.

5.

Molecular basis of lysophosphatidic acid-induced NF-κB activation.

Sun W, Yang J.

Cell Signal. 2010 Dec;22(12):1799-803. doi: 10.1016/j.cellsig.2010.05.007. Epub 2010 May 12. Review.

6.

Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation.

Sun J, Lin X.

Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17085-90. doi: 10.1073/pnas.0802701105. Epub 2008 Oct 24.

7.
8.

beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53.

Boularan C, Scott MG, Bourougaa K, Bellal M, Esteve E, Thuret A, Benmerah A, Tramier M, Coppey-Moisan M, Labbé-Jullié C, Fåhraeus R, Marullo S.

Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18061-6. Epub 2007 Nov 5.

Supplemental Content

Support Center